← Leaderboards
Nicola Abate
University Of Texas Sw Med Ctr/Dallas
$3,858,061
Attributed
$3,858,061
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $524.4K · FY2005–09$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$3,858,061 · 12
By mechanism
M01$1,720,653 · 7
R01$1,477,040 · 1
K23$616,950 · 1
P41$43,418 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Texas Sw Med Ctr/Dallas
Same institution · by research overlap
- Eunsook Jin$1,517,775
- Khashayar Sakhaee$14,492,169
- Christopher B Newgard$30,587,994
- Ishwarlal Jialal$7,903,141
- Craig R. Malloy$13,817,010
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectObesityResearch PersonnelDiabetes MellitusInsulinInsulin ResistanceBiopsyInsulin Sensitivity /ResistanceAdipose TissueMetabolicEthnic Minority PopulationEvaluationBody FatEsterified Fatty AcidsFatty Acid Glycerol EstersPlasmaNon-DiabeticNon ObesePredispositionVolunteerComputer Retrieval Of Information On Scientific Projects DatabaseMetabolic SyndromeInstitution
Grant awards (25)
Role of ENPP1 in insulin resistance without obesity$278,233
R01 · FY2009 · DK · contact PI
ROLE OF ENPP1 IN INSULIN RESISTANCE WITHOUT OBESITY$17,838
P41 · FY2009 · RR · contact PI
A PILOT STUDY ON TREATMENT EFFECT OF TOMATO LYCOPENE AND SOY ISOFLAVONES ON$5,881
M01 · FY2009 · RR · contact PI
Role of ENPP1 in insulin resistance without obesity$280,623
R01 · FY2008 · DK · contact PI
ROLE OF ENPP1 IN INSULIN RESISTANCE WITHOUT OBESITY$10,458
P41 · FY2008 · RR · contact PI
Role of ENPP1 in insulin resistance without obesity$297,729
R01 · FY2007 · DK · contact PI
ROLE OF ENPP1 IN INSULIN RESISTANCE WITHOUT OBESITY$15,122
P41 · FY2007 · RR · contact PI
ROLE OF ENPP1 IN INSULIN RESISTANCE WITHOUT OBESITY$8,529
M01 · FY2007 · RR · contact PI
METABOLIC AND GENETIC DETERMINANTS OF INSULIN RESISTANCE$5,190
M01 · FY2007 · RR · contact PI
Role of ENPP1 in insulin resistance without obesity$306,621
R01 · FY2006 · DK · contact PI
METABOLIC AND GENETIC DETERMINANTS OF INSULIN RESISTANCE$30,405
M01 · FY2006 · RR · contact PI
Role of ENPP1 in insulin resistance without obesity$313,834
R01 · FY2005 · DK
METABOLIC AND GENETIC DETERMINANTS OF INSULIN RESISTANCE$210,560
M01 · FY2005 · RR
Metabolic and Genetic Determinants of Insulin Resistance$139,754
M01 · FY2004 · RR
Mentored Patient Oriented Research Career Development Aw$123,390
K23 · FY2004 · RR
Mentored Patient Oriented Research Career Development Aw$123,390
K23 · FY2003 · RR
NITRIC OXIDE, INSULIN RESISTANCE &HYPERTENSION IN HUMANS$321,374
M01 · FY2002 · RR
EFFECTS OF K MG CITRATE ON INSULIN SENSITIVITY IN GOUTY DIATHESIS$321,374
M01 · FY2002 · RR
Mentored Patient Oriented Research Career Development Aw$123,390
K23 · FY2002 · RR
EFFECTS OF K MG CITRATE ON INSULIN SENSITIVITY IN GOUTY DIATHESIS$321,374
M01 · FY2001 · RR
NITRIC OXIDE, INSULIN RESISTANCE &HYPERTENSION IN HUMANS$321,374
M01 · FY2001 · RR
Mentored Patient Oriented Research Career Development Aw$123,390
K23 · FY2001 · RR
Mentored Patient Oriented Research Career Development Aw$123,390
K23 · FY2000 · RR
NITRIC OXIDE, INSULIN RESISTANCE &HYPERTENSION IN HUMANS$34,838
M01 · FY2000 · RR
EFFECTS OF K MG CITRATE ON INSULIN SENSITIVITY IN GOUTY DIATHESIS$0
M01 · FY2000 · RR